siRNA Primary Cell Transfection Reagent V2

Inner components should be stored according to specified temperature. siRNA Primary Cell Transfection Reagent V2 is an upgraded version of the primary cell small nucleic acid transfection reagent. Compared to the primary cell small nucleic acid transfection reagent，the siRNA Primary Cell Transfection Reagent V2 kit includes an siRNA transfection enhancer that effectively reduces immune rejection reactions at the cell membrane，significantly improving siRNA transfection efficiency. siRNA Primary Cell Transfection Reagent V2 achieves higher siRNA transfection efficiency，with positive transfection rates exceeding 90% in certain primary cell types—5-30% higher than the original primary cell small RNA transfection reagent. V2 can transfect small RNA molecules under 200 bp，including siRNA，miRNA mimics，and miRNA inhibitors，and is effective for most primary cell types. V2 efficiently transfects most primary cells，achieving ideal gene knockout effects. It even delivers satisfactory transfection results in live parasitic larvae. Utilizing novel biodegradable nanomaterials，V2 exhibits low cytotoxicity with only approximately 5% cell death during transfection. Serum does not affect V2‘s transfection efficacy，eliminating the need for specialized low-serum media or medium changes 4-6 hours post-transfection，thereby simplifying researcher workflows. Features: 1. Primary cell transfection performance: Typically achieves over 90% transfection efficiency with pronounced knockout effects; primary hepatocyte Lamin A/C knockout efficiency exceeds 95%; 2. Extremely low cytotoxicity: Transfection-induced cell mortality is only about 5%，significantly reducing the impact of cytotoxicity on experimental results; 3. Broad transfection applicability: Most primary cell types achieve satisfactory transfection outcomes.